Edwards Lifesciences
1,081 hedge funds and large institutions have $41.1B invested in Edwards Lifesciences in 2020 Q3 according to their latest regulatory filings, with 124 funds opening new positions, 393 increasing their positions, 373 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 1,045 → 1,081 (+36)
1.06% more ownership
Funds ownership: 81.8% → 82.86% (+1.1%)
5% more repeat investments, than reductions
Existing positions increased: 393 | Existing positions reduced: 373
Holders
1,081
Holding in Top 10
19
Calls
$220M
Puts
$142M
Top Buyers
| 1 | +$469M | |
| 2 | +$257M | |
| 3 | +$130M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$113M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$94.9M |
Top Sellers
| 1 | -$142M | |
| 2 | -$123M | |
| 3 | -$114M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$109M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$100M |